AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

The Jan. 22 report noted the challenges of distributing vaccines among different communities with varying risk factors.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Over the course of two decades, China has built a public health aid program for the world, turbocharged by the pandemic. As ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Hungarys National Centre for Public Health and Pharmacy (NNGYK) is purchasing COVID-19 vaccines for adults and children from ...

Sri Lanka received another consignment of Sinopharm COVID-19 vaccines today (July 02), says State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana. A charter ...